Aller au contenu principal
Profil bibliographique

Marie‐Odile Jauberteau

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

245Publications signalées
4529Citations signalées
3Affiliations récentes

Les institutions déclarées

Les domaines associés

Microfluidic and Bio-sensing TechnologiesTrypanosoma species research and implicationsVasculitis and related conditionsMicrowave and Dielectric Measurement TechniquesSystemic Lupus Erythematosus Research

Les publications récentes

2025 article OpenAlex

Specific serum and skin immunological profiles of patients with bullous pemphigoid requiring biologics

Salomé Fourmound, Stéphanie Dumonteil, Hussein Akil, Damien Audevard et autres

Bullous pemphigoid mainly affects older people with various comorbidities. The disease has a high mortality rate due to the disease itself and to the side effects of systemic treatments. The aim of this study was to identify blood and skin predictive factors …

Maroc, fr (code pays fourni par la source)

0 citations British Journal of Dermatology
Accès ouvert 2024 article OpenAlex

Extracellular vesicles from type-2 macrophages increase the survival of chronic lymphocytic leukemia cells ex vivo

I.A. Lea, N. Ratti, Stéphanie Durand, Rémy Formento et autres

The resistance of Chronic Lymphocytic Leukemia (CLL) B-cells to cell death is mainly attributed to interactions within their microenvironment, where they interact with various types of cells. Within this microenvironment, CLL-B-cells produce and bind cytokines, growth factors, and extracellular vesicles (EVs). In …

fr (code pays fourni par la source)

7 citations Cancer Gene Therapy
Accès ouvert 2024 article OpenAlex

Targeting the NTSR2/TrkB oncogenic pathway in chronic lymphocytic leukemia

I.A. Lea, May Yassine, Boutaîna Chandouri, Léa Rivière et autres

Current therapies that target the B-cell receptor pathway or the inhibition of anti-apoptotic proteins do not prevent the progressive forms of chronic lymphocytic leukemia (CLL), have low long-term efficacy and are subject to therapeutic resistance. Deciphering the mechanisms of leukemic cell survival …

fr (code pays fourni par la source)

2 citations Scientific Reports
Accès ouvert 2023 preprint OpenAlex

Extracellular vesicles from Nurse-Like Cells and THP1-derived Type-2 macrophages transfer aggressiveness to chronic lymphocytic leukemia cells

Paul‐François Gallet, I.A. Lea, N. Ratti, Stéphanie Durand et autres

Abstract The resistance of leukemic B cells to cell death is mainly associated with interactions within the tumor microenvironment, where they interact with various types of cells. Within this microenvironment, CLL B cells produce and bind cytokines, growth factors, and microvesicles. In …

fr (code pays fourni par la source)

0 citations Research Square
Accès ouvert 2023 preprint OpenAlex

Involvement of prohibitins in an oncogenic protein complex in Chronic Lymphocytic Leukemia

Paul‐François Gallet, I.A. Lea, Valar Franklin, Clive S. D’Santos et autres

Abstract Prohibitins (PHB1 and PHB2) are highly conserved and ubiquitously expressed proteins that are mainly localized in the mitochondria. They have been reported to have multiple functions, which can vary depending on their cellular localization and cell type. They are implicated in …

fr (code pays fourni par la source)

0 citations Research Square
Accès ouvert 2023 article OpenAlex

Use of high-plex data provides novel insights into the temporal artery processes of giant cell arteritis

Simon Parreau, Elsa Molina, Stéphanie Dumonteil, Radjiv Goulabchand et autres

Objective: spatial profiling of molecules involved in the temporal arteries of GCA patients and controls. Furthermore, we performed pharmacogenomic network analysis to identify potential treatment targets. Methods: Using human formalin-fixed paraffin-embedded temporal artery biopsy samples (GCA, n = 9; controls, n = …

fr, us (code pays fourni par la source)

17 citations Frontiers in Immunology
Accès ouvert 2022 article OpenAlex

Detection of Glycosylated Markers From Cancer Stem Cells With ColoSTEM Dx Kit for Earlier Prediction of Colon Cancer Aggressiveness

Sabrina Blondy, Stéphanie Durand, Aurélie Lacroix, Niki Christou et autres

Nowadays, colon cancer prognosis still difficult to predict, especially in the early stages. Recurrences remain elevated, even in the early stages after curative surgery. Carcidiag Biotechnologies has developed an immunohistochemistry (IHC) kit called ColoSTEM Dx, based on a MIX of biotinylated plant …

fr (code pays fourni par la source)

5 citations Frontiers in Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.